| ETRGF Stock | | | USD 0 0 42.65% |
Insider
Alexandre Sibilev is VicePres Compliance of Entourage Health Corp
| Web | https://entouragehealthcorp.com |
Entourage Health Management Efficiency
The company has return on total asset
(ROA) of
(0.1885) % which means that it has lost $0.1885 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(3.711) %, meaning that it generated substantial loss on money invested by shareholders. Entourage Health's management efficiency ratios could be used to measure how well Entourage Health manages its routine affairs as well as how well it operates its assets and liabilities.
Entourage Health Corp has accumulated 4.57
M in total debt. Entourage Health Corp has a current ratio of 3.53, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Entourage Health until it has trouble settling it off, either with new capital or with free cash flow. So, Entourage Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entourage Health Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entourage to invest in growth at high rates of return. When we think about Entourage Health's use of debt, we should always consider it together with cash and equity.
Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health is traded on OTC Exchange in the United States. Entourage Health Corp [ETRGF] is a
Pink Sheet which is traded through a dealer network over-the-counter (OTC).
Management Performance
Entourage Health Corp Leadership Team
Elected by the shareholders, the Entourage Health's board of directors comprises two types of representatives: Entourage Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Entourage. The board's role is to monitor Entourage Health's management team and ensure that shareholders' interests are well served. Entourage Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Entourage Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Deborah Sikkema, Chief Officer | |
| Jeff Keyes, VP Operations | |
| Vaani Maharaj, Chief Officer | |
| George Scorsis, Ex CEO | |
| Joseph Mele, Chief Officer | |
| Alexandre Sibilev, VicePres Compliance | |
| Marianella delaBarrera, Sr Affairs | |
| James Afara, Chief Officer | |
| Jonas Vanderzwan, Medical Board | |
| Michael Kraft, Strategic board | |
Entourage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Entourage Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Entourage Pink Sheet
Entourage Health financial ratios help investors to determine whether Entourage Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entourage with respect to the benefits of owning Entourage Health security.